Nobuaki Fujikuni, Kazuaki Tanabe, Minoru Hattori, Yuji Yamamoto, Hirofumi Tazawa, Kazuhiro Toyota, Noriaki Tokumoto, Ryuichi Hotta, Senichiro Yanagawa, Yoshihiro Saeki, et al. Distal Gastrectomy for Symptomatic Stage IV Gastric Cancer Contributes to Prognosis with Acceptable Safety Compared to Gastrojejunostomy. Cancers. 2022. 14. 2
Hirofumi Tazawa, Takahisa Suzuki, Akihisa Saito, Akira Ishikawa, Toshiaki Komo, Haruki Sada, Norimitsu Shimada, Naoto Hadano, Takashi Onoe, Takeshi Sudo, et al. Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2021. 26. 2. 305-313
Toshiaki Komo, Takahisa Suzuki, Hirofumi Tazawa, Haruki Sada, Hiroshi Morimoto, Norimitsu Shimada, Naoto Hadano, Takashi Onoe, Takeshi Sudo, Yosuke Shimizu, et al. Clinical complete response after nivolumab administered as a third-line treatment for unresectable advanced gastric cancer with peritoneal dissemination: A case report. International journal of surgery case reports. 2021. 84. 106161-106161
Our experience of the treatment with Nivolumab for advanced gastric cancer
(13th International Gastric Cancer Congress 2019)
Effects of FcγRs and C1qA polymorphisms on the response to rituximab and on the survival of recipients of ABO-incompatible organ allografts
(American Transplant Congress 2012)
Blockade of invariant TCR-CD1d interaction specifically inhibits antibody production against blood group carbohydrates
(American Transplant Congress 2011)
Differential susceptibility of B cell subpopulations to proteasome inhibition: Bortezomib targets both B-1-like blasts and plasma cells and reduces the alloantibody, anti-blood-group antibody and anti-Gal antibody level
(American Transplant Congress 2011)
Persistent absence of B cells with receptors for donor-type blood group antigens in ABO-incompatible liver transplant patients treated with an immunosuppressive regimen containing rituximab and calcineurin inhibitors
(American Transplant Congress 2010)